European Pharmacovigilance Congress 2025
EnglishEnglishPanoramica della conferenza
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences for the very high scientific content.
The high value of the 2025 congress edition is assured by the Scientific Advisory Group: a team of internationally renown key opinion leaders in charge of defining the congress content and
identifying the most knowledgeable, prestigious and eloquent speakers.
This year the importance of the congress will further increase thanks to the collaboration of the Institute of Pharmacovigilance.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
EUPV Congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
The 8th European Pharmacovigilance Congress: speaker abstracts 2024
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress 2025 will be a mixed event!
21-22 November | Virtual 9 am – 6 pm
27 November | PV Workshop + Evening Cocktail, NH Milano Congress Centre 5 – 9 pm
28 November | Face to face, NH Milano Congress Centre 9 am – 5 pm
EVENING COCKTAIL November 27 from 6 to 9 pm
At the conference venue, PEC organizes a Welcome evening cocktail that will take place together with interesting workshops. Reserve your place to meet and network with your colleagues and experts!
This year the congress will includes:
– 22 Topics
– 20 interactives round tables
– 6 virtual parallel sessions
– 2 face to face parallel workshops
– 2 LECTIO Magistralis
Perchè partecipare?
- Learn about the latest Pharmacovigilance trends and updates
- Share experiences and solutions at a leading European event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies Delegates and Speakers
A chi è rivolto?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
TOPICS 2025 IN PROGRESS
- ADVANCING SIGNAL DETECTION IN PHARMACOVIGILANCE: MODERN METHODOLOGIES AND BEST PRACTICES
- IMMUNOLOGICALLY DRIVEN ADVERSE REACTIONS
- INTEGRATING REAL WORD DATA AND EVIDENCE IN PV
- PATIENTS’ ASSOCIATIONS CONTRIBUTION TO PV
- ANTIBODIES’ INFLUENCE ON THE SAFETY PROFILE OF BIOLOGICAL PRODUCTS
- SAFETY OF COMBINATION PRODUCTS
- AUTHORITIES’ REVIEW OF PV DATA FROM MARKETING AUTHORIZATION APPLICATION TO WHEN THINGS GO WRONG
- PRAC AND OTHER EUROPEAN AUTHORITY PROCESSES FOR MONITORING THE BENEFIT RISK OF DRUGS
- LABELLING: A FUNDAMENTAL RISK COMMUNICATION AND MINIMIZATION TOOL
- REGULATORY ASPECTS FOR IMPLEMENTING ARTIFICIAL INTELLIGENCE IN PV
- PRACTICAL EXAMPLES OF AI IMPLEMENTATION IN PV PROCESSES
- APPLYING THEORY OF GAMES IN PV: HOW CAN WE AUTOMATE REINFORCED LAERNING FOR PV LARGE LANGUAGE MODELS?
- AGGREGATE REPORTS AROUND THE WORLD
- RISK MANAGEMENT
- OVERCOMING CHALLENGES AND PRIORITIZING VALUE IN THE EVOLVING PV LANDSCAPE
- NEW SKILLS NEEDED IN PV
- PERSONALIZED PV
- BENEFIT-RISK EVALUATION OF MEDICINAL PRODUCTS
- PV AUDITS & INSPECTIONS
Non ci sono sessioni in agenda.
Scientific Advisory Group 2025
Felix Arellano
Senior Vice President and the Global Head of Safety & Risk Management | Roche
Andrew Bate
VP, Head of Safety Innovation & Analytics | GSK
Glyn Belcher
Honorary Member Scientific Advisory Group EUPV Congress 2025
Mattia Calissano
Head of Pharmacovigilance | Orchard Therapeutics
Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Head of Pharmacovigilance and QPPV
Mircea Ciuca
Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Giovanni Furlan
Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Calin A. Lungu
DDCS S.A., CEO
Hrvoje Maček
VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Valentina Mancini
Senior Director Pharmacovigilance, QPPV | Shionogi Europe
Jan Petracek
CEO | iVigee, Director | Institute of Pharmacovigilance
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech
SPEAKERS 2025 IN PROGRESS
MEDIA PARTNER/COLLABORATIONS/SPONSORS 2025 IN PROGRESS
Sage
Media Partner
Sage
Media Partner
Published by SAGE, Therapeutic Advances in Drug Safety (Impact Factor: 3.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the 6th edition of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
E-mail: shasha.sharief@sagepub.co.uk
Twitter: @TADrugSafety
Visita il sito »
Institute of Pharmacovigilance
Collaboration
Institute of Pharmacovigilance
Collaboration
Founded in 2015, the Institute of Pharmacovigilance (IPV) is a not-for-profit, non-governmental global organization with a clear goal – to elevate the pharmacovigilance industry by competency and seniority certification.
In 2020, IPV partnered with the International Society of Pharmacovigilance (ISoP) to develop the Global Pharmacovigilance Professional Certification (GPPC), creating a globally recognized standard for PV professionals. The certification works with competency standards including knowledge, skills and attitudes suitable for every role in pharmacovigilance.
Committed to continuous innovation, IPV regularly updates its programs to reflect the latest advancements, ensuring certified professionals have practical knowledge and skills they can apply in their jobs immediately.
Visita il sito »
Insuvia
Exhibitor
Insuvia
Exhibitor
Insuvia is designed to act as a pharmacovigilance unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance challenges that pharmaceutical companies encounter while commercializing their products.
Visita il sito »
iVigee
Platinum Sponsor
iVigee
Platinum Sponsor
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle.
We combine years of experience with the latest innovative AI technologies to create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand.
Our teams support clients around the world with progressive pharmacovigilance and data management requirements from our strategic bases in Central Europe and the US East Coast.
iVigee: Simple. Powerful. Elegant.
Visita il sito »
Diventa sponsor
Don’t miss the chance to be a European Pharmacovigilance Congress 2025 sponsor!
Contact us to learn about our sponsorship packages, you will have the opportunity to:
• Deliver a talk in person or online
• Conduct a parallel session during the day in Milan
• Network and connect with your target customers
Sede del congresso
Step 1
On November 19-20 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
COCKTAIL DINNER November 27, 2025 (NH Milano Congress Centre, in Assago, Milan)
Let’s finally meet face to face in Milan on November 28! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
If you need Visa, contact in**@ph*******************.it. Please, consider that we apply a fee for the Visa Request Letter Service.
Arrivare in aereo
From Malpensa Airport:
-
- take the bus to the central station, then the subway towards Assago Milanofiori Forum
- take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.
From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.
Arrivare in treno
From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.
Arrivare in tram
From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.
Edizioni precedenti
Panoramica della conferenza
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences for the very high scientific content.
The high value of the 2025 congress edition is assured by the Scientific Advisory Group: a team of internationally renown key opinion leaders in charge of defining the congress content and
identifying the most knowledgeable, prestigious and eloquent speakers.
This year the importance of the congress will further increase thanks to the collaboration of the Institute of Pharmacovigilance.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
EUPV Congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
The 8th European Pharmacovigilance Congress: speaker abstracts 2024
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress 2025 will be a mixed event!
21-22 November | Virtual 9 am – 6 pm
27 November | PV Workshop + Evening Cocktail, NH Milano Congress Centre 5 – 9 pm
28 November | Face to face, NH Milano Congress Centre 9 am – 5 pm
EVENING COCKTAIL November 27 from 6 to 9 pm
At the conference venue, PEC organizes a Welcome evening cocktail that will take place together with interesting workshops. Reserve your place to meet and network with your colleagues and experts!
This year the congress will includes:
– 22 Topics
– 20 interactives round tables
– 6 virtual parallel sessions
– 2 face to face parallel workshops
– 2 LECTIO Magistralis
Perchè partecipare?
- Learn about the latest Pharmacovigilance trends and updates
- Share experiences and solutions at a leading European event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies Delegates and Speakers
A chi è rivolto?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
TOPICS 2025 IN PROGRESS
- ADVANCING SIGNAL DETECTION IN PHARMACOVIGILANCE: MODERN METHODOLOGIES AND BEST PRACTICES
- IMMUNOLOGICALLY DRIVEN ADVERSE REACTIONS
- INTEGRATING REAL WORD DATA AND EVIDENCE IN PV
- PATIENTS’ ASSOCIATIONS CONTRIBUTION TO PV
- ANTIBODIES’ INFLUENCE ON THE SAFETY PROFILE OF BIOLOGICAL PRODUCTS
- SAFETY OF COMBINATION PRODUCTS
- AUTHORITIES’ REVIEW OF PV DATA FROM MARKETING AUTHORIZATION APPLICATION TO WHEN THINGS GO WRONG
- PRAC AND OTHER EUROPEAN AUTHORITY PROCESSES FOR MONITORING THE BENEFIT RISK OF DRUGS
- LABELLING: A FUNDAMENTAL RISK COMMUNICATION AND MINIMIZATION TOOL
- REGULATORY ASPECTS FOR IMPLEMENTING ARTIFICIAL INTELLIGENCE IN PV
- PRACTICAL EXAMPLES OF AI IMPLEMENTATION IN PV PROCESSES
- APPLYING THEORY OF GAMES IN PV: HOW CAN WE AUTOMATE REINFORCED LAERNING FOR PV LARGE LANGUAGE MODELS?
- AGGREGATE REPORTS AROUND THE WORLD
- RISK MANAGEMENT
- OVERCOMING CHALLENGES AND PRIORITIZING VALUE IN THE EVOLVING PV LANDSCAPE
- NEW SKILLS NEEDED IN PV
- PERSONALIZED PV
- BENEFIT-RISK EVALUATION OF MEDICINAL PRODUCTS
- PV AUDITS & INSPECTIONS
Non ci sono sessioni in agenda.
Scientific Advisory Group 2025
Felix Arellano
Senior Vice President and the Global Head of Safety & Risk Management | Roche
Andrew Bate
VP, Head of Safety Innovation & Analytics | GSK
Glyn Belcher
Honorary Member Scientific Advisory Group EUPV Congress 2025
Mattia Calissano
Head of Pharmacovigilance | Orchard Therapeutics
Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Head of Pharmacovigilance and QPPV
Mircea Ciuca
Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Giovanni Furlan
Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Calin A. Lungu
DDCS S.A., CEO
Hrvoje Maček
VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Valentina Mancini
Senior Director Pharmacovigilance, QPPV | Shionogi Europe
Jan Petracek
CEO | iVigee, Director | Institute of Pharmacovigilance
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech
SPEAKERS 2025 IN PROGRESS
MEDIA PARTNER/COLLABORATIONS/SPONSORS 2025 IN PROGRESS
Sage
Media Partner
Sage
Media Partner
Published by SAGE, Therapeutic Advances in Drug Safety (Impact Factor: 3.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the 6th edition of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
E-mail: shasha.sharief@sagepub.co.uk
Twitter: @TADrugSafety
Visita il sito »
Institute of Pharmacovigilance
Collaboration
Institute of Pharmacovigilance
Collaboration
Founded in 2015, the Institute of Pharmacovigilance (IPV) is a not-for-profit, non-governmental global organization with a clear goal – to elevate the pharmacovigilance industry by competency and seniority certification.
In 2020, IPV partnered with the International Society of Pharmacovigilance (ISoP) to develop the Global Pharmacovigilance Professional Certification (GPPC), creating a globally recognized standard for PV professionals. The certification works with competency standards including knowledge, skills and attitudes suitable for every role in pharmacovigilance.
Committed to continuous innovation, IPV regularly updates its programs to reflect the latest advancements, ensuring certified professionals have practical knowledge and skills they can apply in their jobs immediately.
Visita il sito »
Insuvia
Exhibitor
Insuvia
Exhibitor
Insuvia is designed to act as a pharmacovigilance unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance challenges that pharmaceutical companies encounter while commercializing their products.
Visita il sito »
iVigee
Platinum Sponsor
iVigee
Platinum Sponsor
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle.
We combine years of experience with the latest innovative AI technologies to create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand.
Our teams support clients around the world with progressive pharmacovigilance and data management requirements from our strategic bases in Central Europe and the US East Coast.
iVigee: Simple. Powerful. Elegant.
Visita il sito »
Diventa sponsor
Don’t miss the chance to be a European Pharmacovigilance Congress 2025 sponsor!
Contact us to learn about our sponsorship packages, you will have the opportunity to:
• Deliver a talk in person or online
• Conduct a parallel session during the day in Milan
• Network and connect with your target customers
Sede del congresso
Step 1
On November 19-20 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
COCKTAIL DINNER November 27, 2025 (NH Milano Congress Centre, in Assago, Milan)
Let’s finally meet face to face in Milan on November 28! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
If you need Visa, contact in**@ph*******************.it. Please, consider that we apply a fee for the Visa Request Letter Service.
Arrivare in aereo
From Malpensa Airport:
-
- take the bus to the central station, then the subway towards Assago Milanofiori Forum
- take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.
From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.
Arrivare in treno
From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.
Arrivare in tram
From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.
Edizioni precedenti
Iscriviti alla conferenza
Face to Face (28/11/25) | 400€ |
Virtual (19-20/11/25) | 600€ |
Virtual + Face to Face (19-20/11/25 e 28/11/25) | 750€ |
* Ospedali, università e liberi professionisti ottengono uno sconto del 40% da applicare ai prezzi pubblicati (gli sconti non sono cumulabili).